Cerity Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.92M | Buy |
8,773
+5,742
| +189% | +$1.26M | ﹤0.01% | 1237 |
|
|
2025
Q1 | $679K | Sell |
3,031
-2,353
| -44% | -$527K | ﹤0.01% | 1599 |
|
|
2024
Q4 | $1.65M | Buy |
5,384
+90
| +2% | +$27.6K | ﹤0.01% | 1187 |
|
|
2024
Q3 | $1.59M | Buy |
5,294
+2,566
| +94% | +$770K | ﹤0.01% | 1192 |
|
|
2024
Q2 | $899K | Sell |
2,728
-2,915
| -52% | -$960K | ﹤0.01% | 1272 |
|
|
2024
Q1 | $2.23M | Buy |
5,643
+3,902
| +224% | +$1.54M | 0.01% | 923 |
|
|
2023
Q4 | $613K | Buy |
1,741
+539
| +45% | +$190K | ﹤0.01% | 1182 |
|
|
2023
Q3 | $451K | Sell |
1,202
-487
| -29% | -$183K | ﹤0.01% | 1014 |
|
|
2023
Q2 | $646K | Buy |
1,689
+288
| +21% | +$110K | ﹤0.01% | 1081 |
|
|
2023
Q1 | $485K | Sell |
1,401
-373
| -21% | -$129K | ﹤0.01% | 1299 |
|
|
2022
Q4 | $418K | Buy |
1,774
+912
| +106% | +$215K | ﹤0.01% | 1020 |
|
|
2022
Q3 | $213K | Buy |
862
+111
| +15% | +$27.4K | ﹤0.01% | 1034 |
|
|
2022
Q2 | $227K | Buy |
+751
| New | +$227K | ﹤0.01% | 1029 |
|
|
2021
Q3 | – | Sell |
-709
| Closed | -$255K | – | 728 |
|
|
2021
Q2 | $255K | Sell |
709
-2
| -0.3% | -$719 | 0.01% | 630 |
|
|
2021
Q1 | $200K | Buy |
+711
| New | +$200K | ﹤0.01% | 665 |
|
|
2019
Q2 | – | Sell |
-2,787
| Closed | -$307K | – | 585 |
|
|
2019
Q1 | $307K | Buy |
2,787
+288
| +12% | +$31.7K | 0.02% | 416 |
|
|
2018
Q4 | $245K | Buy |
2,499
+770
| +45% | +$75.5K | 0.02% | 444 |
|
|
2018
Q3 | $213K | Buy |
+1,729
| New | +$213K | 0.01% | 503 |
|